Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating safety, tolerability, pharmacokinetics, and preliminary efficacy of RLS-0071 in newborns with moderate or severe hypoxic-isc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy

Drugs mentioned

• RLS-0071 (RLS-0071)

Snippet

Sponsor: ReAlta Life Sciences, Inc. | Conditions: Hypoxic-Ischemic Encephalopathy | Phase 2 | Status: RECRUITING